Fact 2: Improved Life Expectancy Over the Years
The narrative surrounding FL’s life expectancy has witnessed a significant transformation over the past few decades. Earlier, a diagnosis might have spelled a gloomy prognosis. However, the dawn of innovative medical treatments has redefined this narrative.
The pillars of this transformation are the combined forces of chemotherapy, targeted therapies, and immunotherapy. Chemotherapy, which uses drugs to kill cancer cells or stop them from dividing, has been a mainstay. But its side effects sometimes weigh down its benefits. Enter targeted therapies and immunotherapy. Targeted therapies specifically target cancer cells, minimizing collateral damage to healthy cells. On the other hand, immunotherapy boosts the body’s natural defenses to combat cancer.
Medical communities worldwide have hailed these advancements. Not only are patients living longer post-diagnosis, but the quality of life has also seen a marked improvement. With reduced side-effects and more efficient treatments, many FL patients now lead fulfilling lives, nearly akin to those without the disease.
Another key factor driving this positive shift is the collaboration between researchers globally. Sharing knowledge, resources, and expertise has expedited the development of newer treatments. Clinical trials, in particular, play a pivotal role. They offer patients access to cutting-edge treatments, potentially extending life expectancy even further. (2)
